Eckel-Passow JE - Search Results

1

Expression of endothelin 2 and localized clear cell renal cell carcinoma.

Bot BM, Eckel-Passow JE, LeGrand SN, Hilton T, Cheville JC, Igel T, Parker AS. Bot BM, et al. Hum Pathol. 2012 Jun;43(6):843-9. doi: 10.1016/j.humpath.2011.07.011. Epub 2011 Nov 1. Hum Pathol. 2012. PMID: 22047647 Free PMC article.

2

Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.

Parker AS, Leibovich BC, Lohse CM, Sheinin Y, Kuntz SM, Eckel-Passow JE, Blute ML, Kwon ED. Parker AS, et al. Cancer. 2009 May 15;115(10):2092-103. doi: 10.1002/cncr.24263. Cancer. 2009. PMID: 19296514 Free PMC article.

3

Tissue microarrays: one size does not fit all.

Eckel-Passow JE, Lohse CM, Sheinin Y, Crispen PL, Krco CJ, Kwon ED. Eckel-Passow JE, et al. Diagn Pathol. 2010 Jul 7;5:48. doi: 10.1186/1746-1596-5-48. Diagn Pathol. 2010. PMID: 20609235 Free PMC article.

4

Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing.

Sun Z, Asmann YW, Kalari KR, Bot B, Eckel-Passow JE, Baker TR, Carr JM, Khrebtukova I, Luo S, Zhang L, Schroth GP, Perez EA, Thompson EA. Sun Z, et al. PLoS One. 2011 Feb 25;6(2):e17490. doi: 10.1371/journal.pone.0017490. PLoS One. 2011. PMID: 21364760 Free PMC article.

5

Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2.

Joseph RW, Eckel-Passow JE, Sharma R, Liu P, Parker A, Jakob J, Buchbinder E, Bassett RL, Davies MA, Hwu P, Atkins MB, Sullivan RJ. Joseph RW, et al. J Immunother. 2012 Nov-Dec;35(9):711-5. doi: 10.1097/CJI.0b013e3182742c27. J Immunother. 2012. PMID: 23090080

6

Experimental designs for array comparative genomic hybridization technology.

McDonnell SK, Riska SM, Klee EW, Thorland EC, Kay NE, Thibodeau SN, Parker AS, Eckel-Passow JE. McDonnell SK, et al. Cytogenet Genome Res. 2013;139(4):250-7. doi: 10.1159/000348815. Epub 2013 Mar 27. Cytogenet Genome Res. 2013. PMID: 23548696 Free PMC article. Review.

7

Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma.

Eckel-Passow JE, Serie DJ, Bot BM, Joseph RW, Hart SN, Cheville JC, Parker AS. Eckel-Passow JE, et al. Carcinogenesis. 2014 Apr;35(4):822-7. doi: 10.1093/carcin/bgt485. Epub 2013 Dec 28. Carcinogenesis. 2014. PMID: 24374825 Free PMC article.

8

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.

Joseph RW, Kapur P, Serie DJ, Eckel-Passow JE, Parasramka M, Ho T, Cheville JC, Frenkel E, Rakheja D, Brugarolas J, Parker A. Joseph RW, et al. Cancer. 2014 Apr 1;120(7):1059-67. doi: 10.1002/cncr.28521. Epub 2013 Dec 30. Cancer. 2014. PMID: 24382589 Free PMC article.

9

Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.

Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, Wu KJ, Cheville JC, Leibovich BC. Parker AS, et al. Eur Urol. 2014 Nov;66(5):929-35. doi: 10.1016/j.eururo.2013.12.017. Epub 2013 Dec 25. Eur Urol. 2014. PMID: 24388441 Free PMC article.

10

ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma.

Eckel-Passow JE, Serie DJ, Bot BM, Joseph RW, Cheville JC, Parker AS. Eckel-Passow JE, et al. BMC Urol. 2014 Jan 31;14:14. doi: 10.1186/1471-2490-14-14. BMC Urol. 2014. PMID: 24479813 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters